Delays in dreaming might be an early warning sign of Alzheimer's disease. People who take significantly longer to enter the ...
Patients across the UK will take part in the study where their blood will be tested for a series of proteins - called ...
Taking too long to enter the phase of sleep in which we dream may be an early sign of Alzheimer's disease. This is the ...
Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...
The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
POTOMAC, MD / ACCESS Newswire / January 28, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is proud to announce its selection as one of the top 15 finalists in the PREPARE ...
Delays in dreaming might be an early warning sign of Alzheimer’s disease.People who take significantly longer to ente ...
The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...
New research is drawing a connection between gut health and Alzheimer’s Disease. Scientists at ASU and Banner Alzheimer’s ...
LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...
Alzheimer’s disease is currently the third-leading cause of death among seniors in the U.S., following cardiovascular disease ...
A 2020 study published in Neurology and funded by the National Institute on Aging found that healthy lifestyle ...